Kevin Lorenz
CIK: 0001772558
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FBIO
Fortress Biotech, Inc.
Director
Discretionary Trading P&L
Holdings
About Lorenz Kevin
Lorenz Kevin (SEC CIK 0001772558) files insider reports with the SEC as Director of Fortress Biotech, Inc. (FBIO).
Signal8 holds 2 ownership filings by Lorenz Kevin, all Form 4s, filed between Jan 3, 2025 and Jan 5, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Jan 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lorenz Kevin's filings is in BAY HARBOR ISLANDS, FL.
Recent filings by Lorenz Kevin
Other insiders filing for Fortress Biotech, Inc. (FBIO)
- Jin David, Chief Financial Officer
- ROSENWALD LINDSAY A MD, PRESIDENT, CEO & CHAIRMAN
- WEISS MICHAEL S, Executive Vice Chairman
- Klein Dov, Director
- Harvey Jimmie, Director
- Hoenlein Malcolm, Director